Home › Funds › China Universal Asset Management Co., Ltd. › REGN
China Universal Asset Management Co., Ltd. position in REGN
REGENERON PHARMACEUTICALS · Health Care
China Universal Asset Management Co., Ltd. reported holding 21,862 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$16.4M, representing 0.86% of its reported portfolio and ranking #30 among its reported holdings. China Universal Asset Management Co., Ltd. has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How China Universal Asset Management Co., Ltd.'s REGN position evolved
China Universal Asset Management Co., Ltd. first disclosed a stake in REGN in Q3 2023 at 2,947 shares (US$2.4M). The position peaked in Q4 2024 at 24,674 shares, worth US$17.6M. Across 13 filings, China Universal Asset Management Co., Ltd. increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 21,862 shares valued at US$16.4M — an increase of 2,364 shares quarter over quarter.. Notable position changes include a 249% increase in Q4 2023 (shares rose 10% over the following quarter), a 56% increase in Q1 2024 (shares rose 9% over the following quarter), a 67% increase in Q4 2024 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.95K | $2.43M | New |
| Q4 2023 | 10.30K | $9.04M | Add |
| Q1 2024 | 16.06K | $15.45M | Add |
| Q2 2024 | 9.55K | $10.04M | Reduce |
| Q3 2024 | 14.77K | $15.52M | Add |
| Q4 2024 | 24.67K | $17.58M | Add |
| Q1 2025 | 25.63K | $16.25M | Add |
| Q2 2025 | 24.54K | $12.88M | Reduce |
| Q3 2025 | 21.36K | $12.01M | Reduce |
| Q4 2025 | 19.75K | $15.25M | Reduce |
| Q1 2026 | 21.36K | $16.50M | Add |
| Q2 2026 | 19.50K | $12.16M | Reduce |
| Q3 2026 | 21.86K | $16.41M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- DODGE & COX 4.87M sh · $3.04B · Q2 2026
- Franklin Resources 2.95M sh · $2.75B · Q3 2026
- Nuveen, LLC 1.96M sh · $1.48B · Q3 2026
- LOOMIS SAYLES & CO L P 1.72M sh · $1.30B · Q3 2026
More on China Universal Asset Management Co., Ltd.
FAQ
How long has China Universal Asset Management Co., Ltd. held REGN?
China Universal Asset Management Co., Ltd. has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is China Universal Asset Management Co., Ltd.'s current position in REGN?
As of Q3 2026, China Universal Asset Management Co., Ltd. holds 21.86K shares of REGN (REGENERON PHARMACEUTICALS), valued at $16.41M, representing 0.86% of its reported portfolio and ranking #30.
Has China Universal Asset Management Co., Ltd. been buying or selling REGN?
In the latest 13F filing (Q3 2026), China Universal Asset Management Co., Ltd. increased its position in REGN. The position peaked in Q4 2024 at 24.67K shares.
Which other funds hold REGN?
Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.